Moreover, although direct ascites tumor analyses were not feasible due to effective suppression of tumor growth in dhC16-Cer-treated animals, immunoblots indicated increased CerS2 and CerS6 expression within splenic lysates from representative animals treated with dhC16-Cer relative to vehicle-treated animals (Figure 6E). Here, CERS6 is linked to neoplasm.